Skip to content

Main Navigation

Latham BioPharm Group logo

978.266.9151
  • About Us
    • Who We Are / Mission and Values
    • Business Model / Value Proposition
    • Leadership Team
  • Services
    • Non-dilutive Funding
      • Government Relations
      • Proposal Development
      • Post-award Support
      • Contract Compliance
    • Product Development
      • CMC
      • Regulatory
      • Clinical
      • Nonclinical
      • Discovery
      • Quality
      • Project Management
      • Vendor Management
    • Strategic Consulting
      • Strategic Planning
      • Financial Modeling
      • Market Research
      • Supply Chain Network Development & Optimization
      • Market Access / Launch
      • Due Diligence
      • Technology Scouting
  • Expertise
    • Product Types
      • Vaccines
      • Therapeutics
      • Small Molecules
      • Cell & Gene Therapies
      • Medical Devices
      • Diagnostics
      • Digital Health
      • MCMs
      • Animal Health
    • Sectors
      • LBG Biologics
      • LBG Animal Health
      • LBG Pharma
      • LBG MD&D (Medical Devices, Diagnostics, and Digital Health)
  • Media / Collateral
    • Press Releases
    • News
    • Collateral
    • Case Studies
  • Careers
    • Working at LBG
    • Current Opportunities
  • Contact Us
    • Locations
    • Request a Meeting

Collateral

  • Press Releases
  • News
  • Collateral
  • Case Studies

Collateral

Publications

New Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s

View Publications
Publications

Cost of Goods Analysis Facilitates an Integrated Approach to Identifying Alternative Synthesis Methodologies for Lower Cost Manufacturing of the COVID-19 Antiviral Molnupiravir

View Publications
Whitepaper

Challenges of Commercial-Scale Autologous CART-T Cell Manufacturing

View Whitepaper
Whitepaper

The Importance of ROI Evaluation in the Pharmaceutical/Biotechnology Industry

View Whitepaper
Whitepaper

Innovator Requirements for the Selection of a CAR-T CDMO

View Whitepaper
Whitepaper

Outsourcing Biosimilar Development, BioProcess International’s March 2017 Featured Report

View Whitepaper
Whitepaper

Manufacturing Economics: “Minimizing Costs and Process Times with Local Biomanufacturing”, June 2010, BioProcess International

View Whitepaper
Presentation

Biologics Drug Substance Manufacturing

View Presentation
Presentation

Emerging Techniques and Technologies

View Presentation
Whitepaper

“Single Use Becoming an Established Tool: Vendors’ Attention to Users’ Requirements and Familiarity Are Driving Increased Implementation”, May 15, 2010 (Vol. 30, No. 10), GEN|Genetic Engineering & Biotechnology News

View Whitepaper
12
Next Page »

Interested in our services?

Contact us today to set up an appointment.

Get Started

Footer Navigation

  • About Us
  • Services
    • Non-dilutive Funding
    • Product Development
    • Strategic Consulting
  • Expertise
    • Product Types
    • Sectors
  • Media / Collateral
    • Press Releases
    • News
    • Collateral
    • Case Studies
  • Careers
  • Contact Us

Contact Information

Follow Us
  • LinkedIn
Latham BioPharm Group
Phone: 978.266.9151
Email: Email Us

© Latham BioPharm Group. All rights reserved. | Privacy Policy

This site uses cookies to give you the best, most relevant experience. By continuing to browse the site you are agreeing to our use of cookies. You can find out more about which cookies we are using or switch them off in .

Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.